| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Lin,Yong-Xiang | Chairman | 27.58% | TCI CO., LTD. |
| Fu,Zhen-Zhen | Director | 27.58% | TCI CO., LTD. |
| Chen,Jing-Ting | Director | 27.58% | TCI CO., LTD. |
| Cai,Zhi-Cheng | Director | 27.58% | TCI CO., LTD. |
| Li,Tou-Yuan | Director | 1.54% | ZHONG JIA INVESTMENT DEVELOPMENT CO., LTD. |
| Lai,Shi-Ming | Director | 9.70% | FORMOSA BIOMEDICAL TECHNOLOGY CORPORATION |
| Liao,Song-Yuan | Independent Director | 0.00% | |
| Vacancy | Independent Director | 0.00% | |
| Ceng,Zhong-Ming | Independent Director | 0.00% |
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 177,181 | 680,651 | 622,115 |
| Operating cost | 51,941 | 197,326 | 198,021 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 125,240 | 483,325 | 424,094 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 125,240 | 483,325 | 424,094 |
| Operating expenses | 73,210 | 303,419 | 274,244 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 52,030 | 179,906 | 149,850 |
| Non-operating income and expenses | 7,781 | 45,639 | 43,292 |
| Net profit (loss) before tax | 59,811 | 225,545 | 193,142 |
| Income tax expense (benefits) | 12,723 | 35,378 | 27,314 |
| Net profit (loss) of ongoing business for the current period | 47,088 | 190,167 | 165,828 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 47,088 | 190,167 | 165,828 |
| Other comprehensive profit (loss), net | 55,263 | -122,560 | -66,683 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 102,351 | 67,607 | 99,145 |
| Net profit (loss) attributable to owners of parent company | 47,088 | 190,167 | 165,828 |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | 102,351 | 67,607 | 99,145 |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | 2 | 1 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 74,254 | 298,223 | 171,200 |
| Net cash inflows (outflows) from investing activities | -15,646 | -29,072 | -490,246 |
| Net cash inflow (outflow) from financing activities | 6,900 | -59,729 | -41,393 |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | -1,684 | -1,450 | 573 |
| Increase (decrease) in cash and cash equivalents in the current period | 63,824 | 207,972 | -359,866 |
| Beginning balance of cash and cash equivalents | 639,054 | 431,082 | 790,948 |
| Ending balance of cash and cash equivalents | 702,878 | 639,054 | 431,082 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 878,181 | 830,334 | 619,563 |
| Non-current asset | 818,156 | 752,155 | 873,423 |
| Total asset | 1,696,337 | 1,582,489 | 1,492,986 |
| Current liability | 209,975 | 205,869 | 131,373 |
| Non-current liability | 8,227 | 1,493 | 510 |
| Total liability | 218,202 | 207,362 | 131,883 |
| share capital | 896,801 | 896,761 | 890,298 |
| Equity - secruity token | - | - | - |
| capital reserve | 327,692 | 326,932 | 296,096 |
| retained earning | 391,065 | 344,120 | 244,457 |
| Other equity | -137,423 | -192,686 | -69,748 |
| Treasury stock | - | - | - |
| Total equity attributable to owners of parent company | 1,478,135 | 1,375,127 | 1,361,103 |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 1,478,135 | 1,375,127 | 1,361,103 |
| Share capital awaiting retirement (unit: share) | 0 | 0 | 0 |
| Issued shares of advance equity (unit: shares) | 4,000 | 513,000 | 23,000 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 16 | 15 | 15 |
